On-target effect of FK866, a nicotinamide phosphoribosyl transferase inhibitor, by apoptosis-mediated death in chronic lymphocytic leukemia cells.

Clin Cancer Res

CancerCare Manitoba, Winnipeg, Manitoba, Canada. Manitoba Institute of Cell Biology, Winnipeg, Manitoba, Canada. Departments of Biochemistry and Medical Genetics and Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Published: September 2014

Purpose: Chronic lymphocytic leukemia (CLL) remains incurable despite advances in therapy. In this study, we characterize the effect of nicotinamide phosphoribosyltransferase (NAMPT) inhibition by FK866 in primary CLL cells from patients with various clinical prognostic markers.

Experimental Design: CLL cells were treated with FK866 to assess viability by Annexin V/PI staining. Functional analysis of FK866 included time- and concentration-dependent evaluation of cellular NAD, ATP, mitochondrial membrane potential (MMP), reactive oxygen species (ROS), and apoptotic signaling. Chemosensitization potential by FK866 to fludarabine was also assessed. Prognostic markers were correlated with drug response.

Results: FK866 induced CLL cell death by depleting cellular NAD content by day 1, followed by a drop in ATP on day 2. We observed loss of MMP, ROS increase, and induction of apoptotic signaling at day 3. On-target activity of FK866 was confirmed by NAD-mediated rescue of NAD and ATP loss, apoptotic signaling, and viability. The response to FK866 was independent of most prognostic markers. Higher doses were required with short lymphocyte doubling time and positive CD38 status, whereas CLL cells resistant to fludarabine in vitro and from patients with del17p13.1 were equally sensitive to FK866. FK866 did not upregulate the p53-target p21, nor did the p53 activator Nutlin improve FK866-mediated cell death. Furthermore, fludarabine and FK866 were synergistic at clinically relevant concentrations.

Conclusions: NAMPT inhibition by FK866 may be a potential treatment for CLL, including patients with del17p13.1 or other high-risk features. FK866 may complement standard agents to enhance their efficacy and/or allow dose reduction for improved tolerability.

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0624DOI Listing

Publication Analysis

Top Keywords

fk866
12
cll cells
12
apoptotic signaling
12
chronic lymphocytic
8
lymphocytic leukemia
8
nampt inhibition
8
inhibition fk866
8
cellular nad
8
nad atp
8
prognostic markers
8

Similar Publications

Novel application of metabolic imaging of early embryos using a light-sheet on-a-chip device: a proof-of-concept study.

Hum Reprod

January 2025

Education Program in Reproduction and Development, EPRD, Department of obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.

Study Question: Is it feasible to safely determine metabolic imaging signatures of nicotinamide adenine dinucleotide [NAD(P)H] associated auto-fluorescence in early embryos using a light-sheet on-a-chip approach?

Summary Answer: We developed an optofluidic device capable of obtaining high-resolution 3D images of the NAD(P)H autofluorescence of live mouse embryos using a light-sheet on-a-chip device as a proof-of-concept.

What Is Known Already: Selecting the most suitable embryos for implantation and subsequent healthy live birth is crucial to the success rate of assisted reproduction and offspring health. Besides morphological evaluation using optical microscopy, a promising alternative is the non-invasive imaging of live embryos to establish metabolic activity performance.

View Article and Find Full Text PDF

Decreased nicotinamide adenine dinucleotide (NAD) content has been shown to contribute to metabolic dysfunction during aging, including polycystic ovary syndrome (PCOS). However, the effect of NAD on ovulatory dysfunction in PCOS by regulating glycolysis has not been reported. Based on the observations of granulosa cells (GCs) transcriptome data from the Gene Expression Omnibus (GEO) database, the signal pathways including glycolysis and nicotinate-nicotinamide metabolism were significantly enriched, and most genes of the above pathway like LDHA and SIRT2 were down-regulated in PCOS patients.

View Article and Find Full Text PDF

Unlabelled: Most metastatic prostate cancers (PCa) initially depend on androgen for survival and proliferation. Thus, anti-androgen or castration therapies are the mainstay treatment. Although effective at first, androgen-dependent PCa (ADPC) universally develops therapy resistance, thereby evolving to the incurable disease, called castration resistant PCa (CRPC).

View Article and Find Full Text PDF

Regulatory roles of NAMPT and NAD metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment.

Redox Biol

December 2024

School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, 11031, Taiwan; Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei, 11031, Taiwan; School of Food Safety, College of Nutrition, Taipei Medical University, Taipei, 11031, Taiwan; Nutrition Research Center, Taipei Medical University Hospital, Taipei, 11031, Taiwan; TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei, 11031, Taiwan. Electronic address:

Uterine leiomyoma (UL), commonly referred to as benign tumors, is characterized by excessive cell proliferation, extracellular matrix (ECM) accumulation, and the presence of stem cell-like properties. Nicotinamide adenine dinucleotide (NAD) metabolism, regulated in part by nicotinamide phosphoribosyltransferase (NAMPT), plays a crucial role in these pathological processes and has emerged as a potential therapeutic target. Additionally, redox signaling pathways are integral to the pathogenesis of UL, influencing the dynamics of NAD metabolism.

View Article and Find Full Text PDF
Article Synopsis
  • Visfatin is expressed in the testis across various species, but its specific role in the adult testis was previously unclear and this study aims to clarify it.
  • The injection of FK866, which inhibits visfatin, led to noticeable testicular degeneration and reduced testosterone levels after 24 hours, but parameters normalized after one week.
  • Overall, the study concludes that visfatin plays a crucial role in stimulating testosterone production and testicular growth, and that lingering effects after inhibition may result from compensatory mechanisms in response to the initial decline.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!